The table below shows NEKTAR THERAPEUTICS's income statement line items across its last 6 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
Line item
FY 2025
FY 2024
FY 2023
FY 2022
FY 2021
FY 2020
Revenue
-
-
-
-
-
-
Cost of revenue
$0.00
$30.69M
$33.77M
$21.64M
$24.90M
$19.48M
Gross profit
-
-
-
-
-
-
R&D
$117.33M
$120.91M
$114.16M
$218.32M
$400.27M
$408.68M
SG&A
$68.67M
NKTR annual revenue (10-K history)
NEKTAR THERAPEUTICS reported annual revenue of $55.23M for fiscal year 2025. That is down 43.9% from $98.43M in fiscal 2024. Over the 10 fiscal years shown, annual revenue declined from $165.44M (FY 2016) to $55.23M. Figures come from the company's audited annual reports as filed with the SEC.
